Volume 29, Number 7—July 2023
Research Letter
Isolation of Elizabethkingia spp. from Diagnostic Specimens from Dogs and Cats, United States, 2019–2021
Table 2
Antimicrobial drug | No. tested | No. (%) susceptible |
---|---|---|
Amikacin | 84 | 13 (15) |
Amoxicillin | 57 | 4 (7.0) |
Amoxicillin-clavulanic acid | 57 | 5 (8.8) |
Cefotaxime | 46 | 6 (13) |
Cefovecin | 57 | 5 (8.8) |
Cefpodoxime | 57 | 7 (12) |
Ceftazidime | 86 | 6 (7.0) |
Ceftiofur | 53 | 9 (17) |
Cephalexin | 57 | 3 (5.3) |
Chloramphenicol | 64 | 9 (14) |
Doxycycline | 59 | 39 (66) |
Enrofloxacin | 86 | 73 (85) |
Gentamicin | 85 | 17 (20) |
Imipenem | 86 | 7 (8.1) |
Marbofloxacin | 86 | 75 (87) |
Trimethoprim/sulfamethoxazole | 54 | 48 (89) |
*Antimicrobial susceptibility testing performed according to Clinical and Laboratory Standards Institute guidelines (7) at IDEXX Laboratories (https://www.idexx.com).
References
- Dziuban EJ, Franks JL, So M, Peacock G, Blaney DD. Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017. Clin Infect Dis. 2018;67:144–9. DOIPubMedGoogle Scholar
- US Centers for Disease Control and Prevention. About Elizabethkingia [cited 2022 Dec 16]. https://www.cdc.gov/elizabethkingia/about/index.html
- Lau SK, Chow WN, Foo CH, Curreem SO, Lo GC, Teng JL, et al. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016;6:26045. DOIPubMedGoogle Scholar
- Lee DH, Patel RH, Mehra I, Shenoy R, Nanjappa S, Greene J. A case series of Elizabethkingia meningosepticum bacteremia in the cancer population. Cureus. 2021;13:
e18627 . DOIPubMedGoogle Scholar - Bordelo J, Viegas C, Coelho C, Poeta P. First report of bacteremia caused by Elizabethkingia meningoseptica in a dog. Can Vet J. 2016;57:994.PubMedGoogle Scholar
- Johnson WL, Ramachandran A, Torres NJ, Nicholson AC, Whitney AM, Bell M, et al. The draft genomes of Elizabethkingia anophelis of equine origin are genetically similar to three isolates from human clinical specimens. PLoS One. 2018;13:
e0200731 . DOIPubMedGoogle Scholar - Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; thirty-first informational supplement (M100-S31). Wayne (PA): The Institute; 2021.
- Perrin A, Larsonneur E, Nicholson AC, Edwards DJ, Gundlach KM, Whitney AM, et al. Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain. Nat Commun. 2017;8:15483. DOIPubMedGoogle Scholar
- Hu R, Zhang Q, Gu Z. Whole-genome analysis of the potentially zoonotic Elizabethkingia miricola FL160902 with two new chromosomal MBL gene variants. J Antimicrob Chemother. 2020;75:526–30. DOIPubMedGoogle Scholar
- Comba IY, Schuetz AN, Misra A, Friedman DZP, Stevens R, Patel R, et al. Antimicrobial susceptibility of Elizabethkingia species: report from a reference laboratory. J Clin Microbiol. 2022;60:
e0254121 . DOIPubMedGoogle Scholar
Page created: May 23, 2023
Page updated: June 21, 2023
Page reviewed: June 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.